MB Endobioaisma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 225 |
| - |
| -306 |
| -306 |
| - |
| 5.78 |
| -136.00 |
| -6 |
| 135 |
| 0 |
| 129 |
| -0.03 |
| -22.50 |
| - |
| - |
| -136.00 |
| -306 |
| 2025 |
|---|
| 915 |
| - |
| 322 |
| 303 |
| - |
| 65.57 |
| 33.11 |
| 298 |
| 19 |
| 0 |
| 317 |
| 0.33 |
| 0.06 |
| - |
| - |
| 35.19 |
| 322 |
| 2025 |
|---|
| 915 |
| - |
| 322 |
| 303 |
| - |
| 65.57 |
| 33.11 |
| 298 |
| 19 |
| 0 |
| 317 |
| 0.33 |
| 0.06 |
| - |
| - |
| 35.19 |
| 322 |
Turnover (€)
2025
Turnover (€)
915 €307 % *
Sales per employee (€)
-Profit before tax (€)
322 €205 % *
Net Profit (€)
303 €199 % *
Profit per employee (€)
-Total profitability (%)
65.57 %1,034.43 % *
Net profitability (%)
33.11 %124.35 % *
Equity (€)
298 €5,067 % *
Amounts Payable And Liabilities (€)
19 €-86 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
317 €146 % *
Working capital requirement
0.33 1,200.00 % *
Debt-to-equity ratio
0.06 100.27 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
35.19 %125.88 % *
EBIT (€)
322 €205 % *
